Literature DB >> 6861847

Pharmacodynamic and pharmacokinetic interactions between ketamine and diazepam.

J Idvall, K F Aronsen, P Stenberg, L Paalzow.   

Abstract

Anaesthesia with continuous i.v. ketamine and 65% nitrous oxide in oxygen was given to a total of 49 patients undergoing major abdominal surgery. A control group was premedicated with atropine and other groups received in addition rectal diazepam or clorazepate i.v. For further patients had been on oral diazepam or barbiturates for 1-14 years; as premedication they received atropine alone. The anaesthetic technique gave good operative conditions in the 4 groups of patients. The haemodynamic stimulation of ketamine was significantly reduced in patients premedicated with diazepam. Psychotomimetic side effects were not prominent in any of the groups. Patients premedicated with diazepam required a lower rate of ketamine infusion as compared to controls during the initial 30 min of anaesthesia. The patients in the other groups did not differ from the control group in this respect. There were large differences in metabolic pattern between the groups. As compared to the controls, the patients on long-term diazepam or barbiturates had high concentrations of hydroxylated metabolites, with levels higher than that of norketamine. The patients pretreated with diazepam had very low plasma levels of hydroxylated metabolites. Clorazepate premedication did not significantly affect the metabolism of ketamine. The biological half-life of ketamine was significantly increased in the diazepam-treated group, and it was shortened in those on long term treatment with barbiturates or diazepam.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861847     DOI: 10.1007/bf00610051

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  Interaction between sedative premedicants and ketamine in man in isolated perfused rat livers.

Authors:  J N Lo; J F Cumming
Journal:  Anesthesiology       Date:  1975-09       Impact factor: 7.892

2.  Plasma-diazepam in infants after rectal administration in solution and by suppository.

Authors:  F U Knudsen
Journal:  Acta Paediatr Scand       Date:  1977-09

3.  Ketamine-iorazepam. Attenuation of psychic sequelae of ketamine by lorazepam.

Authors:  J W Dundee; J K Lilburn
Journal:  Anaesthesia       Date:  1978-04       Impact factor: 6.955

4.  Rise in plasma free-norepinephrine during anesthetic induction with ketamine.

Authors:  E K Zsigmond; R C Kelsch; S P Kothary
Journal:  Behav Neuropsychiatry       Date:  1974 Apr-1975 Mar

5.  Circulatory responses to ketamine anesthesia.

Authors:  W A Tweed; M Minuck; D Mymin
Journal:  Anesthesiology       Date:  1972-12       Impact factor: 7.892

6.  A comparison of psychologic responses to ketamine and thiopental--nitrous oxide--halothane anesthesia.

Authors:  J M Garfield; F B Garfield; J G Stone; D Hopkins; L A Johns
Journal:  Anesthesiology       Date:  1972-04       Impact factor: 7.892

7.  A gas chromatographic assay for ketamine in human plasma.

Authors:  T Chang; A J Glazko
Journal:  Anesthesiology       Date:  1972-04       Impact factor: 7.892

8.  Does ketamine metabolite II exist in vivo?

Authors:  P Stenberg; J Idvall
Journal:  Br J Anaesth       Date:  1981-07       Impact factor: 9.166

9.  An anesthetic agent: 2-orthochlorophenyl, 2-methylamino cyclohexanone HCl (CI-581).

Authors:  R W Virtue; J M Alanis; M Mori; R T Lafargue; J H Vogel; D R Metcalf
Journal:  Anesthesiology       Date:  1967 Sep-Oct       Impact factor: 7.892

10.  Effects of halothane anesthesia on the biodisposition of ketamine in rats.

Authors:  P F White; M P Marietta; C R Pudwill; W L Way; A J Trevor
Journal:  J Pharmacol Exp Ther       Date:  1976-03       Impact factor: 4.030

View more
  7 in total

1.  The use of Hickman-Broviac catheters for paediatric radiotherapy.

Authors:  C A Harrison; J Filshie
Journal:  Ann R Coll Surg Engl       Date:  1986-11       Impact factor: 1.891

2.  Anaesthesia and monitoring for paediatric radiotherapy.

Authors: 
Journal:  J R Soc Med       Date:  1987-03       Impact factor: 5.344

3.  Treatment of experimental status epilepticus with synergistic drug combinations.

Authors:  Jerome Niquet; Roger Baldwin; Lucie Suchomelova; Lucille Lumley; Roland Eavey; Claude G Wasterlain
Journal:  Epilepsia       Date:  2017-02-22       Impact factor: 5.864

Review 4.  Pharmacokinetic drug interactions in anaesthetic practice.

Authors:  M Wood
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

Review 5.  Insights into CYP2B6-mediated drug-drug interactions.

Authors:  William D Hedrich; Hazem E Hassan; Hongbing Wang
Journal:  Acta Pharm Sin B       Date:  2016-08-09       Impact factor: 11.413

Review 6.  Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders.

Authors:  Felicia Ceban; Joshua D Rosenblat; Kevin Kratiuk; Yena Lee; Nelson B Rodrigues; Hartej Gill; Mehala Subramaniapillai; Flora Nasri; Leanna M W Lui; Orly Lipsitz; Anil Kumar; Jung Goo Lee; Edmond H Chau; Bing Cao; Kangguang Lin; Roger C Ho; Rodrigo B Mansur; Jennifer Swainson; Roger S McIntyre
Journal:  CNS Drugs       Date:  2021-08-07       Impact factor: 5.749

Review 7.  Metabolism and metabolomics of ketamine: a toxicological approach.

Authors:  Ricardo Jorge Dinis-Oliveira
Journal:  Forensic Sci Res       Date:  2017-02-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.